
Morphisec
Total Raised
$50MInvestors Count
12Deal Terms
2Funding, Valuation & Revenue
4 Fundings
Morphisec has raised $50M over 4 rounds.
Morphisec's latest funding round was a Series C for $31M on March 25, 2021.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
|---|---|---|---|---|---|---|
3/25/2021 | Series C | $31M | 22 | |||
2/19/2018 | Series B | |||||
10/6/2015 | Series A | |||||
Other Investors |
Date | 3/25/2021 | 2/19/2018 | 10/6/2015 | |
|---|---|---|---|---|
Round | Series C | Series B | Series A | Other Investors |
Amount | $31M | |||
Investors | ||||
Valuation | ||||
Revenue | ||||
Sources | 22 |
Morphisec Deal Terms
2 Deal Terms
Morphisec's deal structure is available for 2 funding rounds, including their Series B from February 19, 2018.
Round | Series B | Series A |
|---|---|---|
Funding Date | ||
Pre-Money Valuation | ||
Post-Money Valuation | ||
Amount Raised | ||
Shares Authorized | ||
Issuance Price | ||
Dividend Rate | ||
Liquidation Preferences | ||
Liquidation Price | ||
Participation | ||
Conversion Price | ||
Anti Dilution | ||
General Voting | ||
Board Voting | ||
Par Value |
Round | Funding Date | Pre-Money Valuation | Post-Money Valuation | Amount Raised | Shares Authorized | Issuance Price | Dividend Rate | Liquidation Preferences | Liquidation Price | Participation | Conversion Price | Anti Dilution | General Voting | Board Voting | Par Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Series B | |||||||||||||||
Series A |
Morphisec Investors
12 Investors
Morphisec has 12 investors. Jerusalem Venture Partners invested in Morphisec's Series C funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
|---|---|---|---|---|---|---|
10/6/2015 | 3/25/2021 | 3 Series A, Series B (2018), Series C (2021) | Venture Capital | Israel | ||
10/6/2015 | 3/25/2021 | DTCP | 3 Series A, Series B (2018), Series C (2021) | Corporate Venture | Germany | |
2/19/2018 | 3/25/2021 | 2 Series B, Series C (2021) | Corporate Venture | France | ||
Corporate Venture | California | |||||
Equity Crowdfunding | Israel |
First funding | 10/6/2015 | 10/6/2015 | 2/19/2018 | ||
|---|---|---|---|---|---|
Last Funding | 3/25/2021 | 3/25/2021 | 3/25/2021 | ||
Investor | DTCP | ||||
Rounds | 3 Series A, Series B (2018), Series C (2021) | 3 Series A, Series B (2018), Series C (2021) | 2 Series B, Series C (2021) | ||
Board Seats | |||||
Type | Venture Capital | Corporate Venture | Corporate Venture | Corporate Venture | Equity Crowdfunding |
Location | Israel | Germany | France | California | Israel |
Compare Morphisec to Competitors

Sysdig focuses on protecting cloud environments, containers, and Kubernetes. The company provides services including cloud security, workload protection, vulnerability management, and security posture management. Sysdig serves sectors that require cloud-native application protection and security management. It was founded in 2013 and is based in San Francisco, California.

OnSystem Logic focuses on cybersecurity with an emphasis on application hardening for endpoints. The company's main offering, OnSystem Defender, provides protection against malware, ransomware, and application vulnerabilities, and integrates with existing endpoint security systems. OnSystem Defender serves sectors that require application security measures, such as financial services, healthcare, and critical infrastructure. It was founded in 2015 and is based in Catonsville, Maryland.

Aqua Security focuses on securing containerized cloud native applications within the cybersecurity sector. The company provides a lifecycle solution that includes pre-deployment hygiene enforcement and real-time attack mitigation for cloud native applications. Aqua's clientele consists of large enterprises that require cloud security. Aqua Security was formerly known as Scalock. It was founded in 2015 and is based in Ramat Gan, Israel.
Doctor Web is an anti-virus security company that develops and markets its products under the brand name Dr.Web. The company offers a range of anti-virus solutions for both businesses and personal use, which protect against computer threats. Doctor Web's products are compatible with various operating systems and applications. It was founded in 1992 and is based in Moscow, Russian Federation.
SecuritySnares focuses on cybersecurity solutions, particularly in the domain of malware prevention and endpoint protection. The company offers products that detect and neutralize ransomware, wiping malware, and unauthorized system beacons to protect operations against cyber threats. SecuritySnares primarily serves sectors that require robust cybersecurity measures to safeguard their digital assets and maintain operational continuity. It was founded in 2017 and is based in Ann Arbor, Michigan.
Vir2us develops security technologies and solutions to deliver cyber-threat immunity in systems. It controls critical infrastructure, financial services, national security, and more from cloud computing servers to laptops. It was founded in 2001 and is based in Petaluma, California.
Loading...

